Table 1.
All Participants n=64 | ATAAD n=21 | pTAA n=43 | |
---|---|---|---|
| |||
Age (years) | 57 (49, 64) | 55 (47, 59) | 60 (53, 65) |
Sex, male | 55 (86) | 18 (86) | 37 (86) |
Body mass index (kg/m2) | 29.9 (26.6, 33.8) | 28.7 (26.6, 32.6) | 30.6 (26.6, 35.2) |
Aortic valve indications | |||
Aortic insufficiency, mod-to-severe | 24 (41) | 4 (24) | 20 (48) |
Aortic stenosis, mod-to-severe | 13 (25) | 2 (14) | 11 (28) |
Bicuspid aortic valve | 23 (36) | 1 (4.8) | 22 (51) |
Thoracic aortic aneurysm | |||
Root | 26 (41) | 7 (33) | 19 (44) |
Ascending | 43 (67) | 8 (38) | 35 (81) |
Arch | 16 (25) | 4 (19) | 12 (28) |
Descending | 1 (16) | 0 (0) | 1 (2.3) |
Max diameter (cm) | 5.3 (4.7, 5.6) | 5.1 (4.5, 5.5) | 5.3 (4.7, 5.7) |
Risk Factors | |||
Hypertension | 50 (78) | 17 (81) | 33 (77) |
Dyslipidemia | 39 (61) | 7 (33) | 32 (74) |
Peripheral vascular disease | 13 (20) | 9 (43) | 4 (9.3) |
Smoking history, former/current | 35 (55) | 12 (57) | 23 (53) |
Diabetes | 10 (16) | 1 (4.8) | 9 (21) |
Chronic lung disease | 6 (9.4) | 0 (0) | 6 (14) |
Chronic kidney disease | 4 (6.2) | 2 (9.5) | 2 (4.6) |
On dialysis | 2 (3.1) | 1 (4.8) | 1 (2.3) |
Coronary artery disease | 20 (31) | 3 (14) | 17 (40) |
History of myocardial infarction | 6 (9.4) | 0 (0) | 6 (14) |
History of stroke | 3 (4.7) | 0 (0) | 3 (7.0) |
History of heart failure | 8 (12) | 1 (4.8) | 7 (16) |
Heart failure within 2 weeks of operation | 2 (3.1) | 0 (0) | 2 (4.7) |
NYHA classification | |||
I | 41 (64) | 18 (86) | 23 (53) |
II | 17 (27) | 2 (9.5) | 15 (35) |
III | 5 (7.8) | 1 (4.8) | 4 (9.3) |
IV | 1 (1.6) | 0 (0) | 1 (2.3) |
Previous cardiac intervention | 14 (22) | 2 (9.5) | 12 (28) |
Previous cardiac surgery | 10 (16) | 2 (9.5) | 8 (19) |
Data presented as median (25%, 75%) for continuous data and n (%) for categorical data.
Abbreviations: ATAAD=acute type A aortic dissection; NYHA=New York heart association; pTAA=thoracic aortic aneurysm.